The team conducting the first-in-human clinical trial of deep brain stimulation for stroke recovery garnered $2.5M to continue parallel preclinical studies of the underlying mechanisms.
One of the largest studies of routinely collected patient-reported outcomes after stroke suggests that executive function and patients’ social participation need more clinical attention.
Here’s a status update from this historic trial, including a rundown of elements being investigated in addition to stroke survivors’ functional outcomes.
A scientist involved in Cleveland Clinic’s newly launched study of neuromodulation for post-stroke recovery speaks to the science behind the trial and the NIH BRAIN grant supporting this work.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The first-in-human trial of neuromodulation for rehabilitative therapy in stroke survivors has been given a boost with a $5 million grant. The lead investigator explains the study’s goals and rationale.
Cleveland Clinic Neurological Institute investigators are hoping that deep brain stimulation (DBS) will prove effective in helping patients regain motor function lost to a stroke.